Emergence of Fluoroquinolone Resistance in Neisseria gonorrhoeae Isolates from Four Clinics in Three Regions of Kenya

dc.contributor.author	Philippe, RS
dc.contributor.author	Sarah, Duncan
dc.contributor.author	Joshua, Kimani,
dc.contributor.author	Alexander, Thiong’o
dc.contributor.author	Juma, Shafi,
dc.contributor.author	Scott, McClelland,
dc.contributor.author	Eduard, Sanders J
dc.contributor.author	George, Zhanel
dc.contributor.author	Nicholas, Maraguri,
dc.contributor.author	Mehta, Supriya D
dc.date.accessioned	2015-07-24T07:43:26Z
dc.date.available	2015-07-24T07:43:26Z
dc.date.issued	2012-05
dc.identifier.citation	Sex Transm Dis. 2012 May; 39(5): 332–334.	en_US
dc.identifier.uri	http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3328140/
dc.identifier.uri	http://hdl.handle.net/11295/88755
dc.description.abstract	We have recently reported high levels of fluoroquinolone resistance in a single region of Kenya. In this manuscript, we report high prevalence of fluoroquinolone resistance (53.2%) in Neisseria gonorrhoeae isolates from four clinics in three additional regions of Kenya. These findings highlight the need to change first-line treatment in these settings and the need to evaluate empiric management guidelines for treatment of gonococcal infection in Kenya.	en_US
dc.language.iso	en	en_US
dc.publisher	University of Nairobi	en_US
dc.subject	Fluoroquinolone, Sexually transmitted disease, gonorrhoea, cefixime, azithromycin	en_US
dc.title	Emergence of Fluoroquinolone Resistance in Neisseria gonorrhoeae Isolates from Four Clinics in Three Regions of Kenya	en_US
dc.type	Article	en_US
dc.type.material	en	en_US